US Stock MarketDetailed Quotes

TARO Taro Pharmaceutical Industries

Watchlist
  • 42.330
  • +0.140+0.33%
Close May 14 16:00 ET
1.59BMarket Cap34.70P/E (TTM)

Taro Pharmaceutical Industries Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
(Q1)Jun 30, 2022
(FY)Mar 31, 2022
(Q4)Mar 31, 2022
Total revenue
12.89%157.15M
13.57%148.2M
1.42%158.89M
2.07%572.95M
2.32%146.59M
0.16%139.2M
-1.13%130.5M
6.49%156.67M
2.25%561.35M
-3.43%143.26M
Operating revenue
12.89%157.15M
13.57%148.2M
1.42%158.89M
2.07%572.95M
2.32%146.59M
0.16%139.2M
-1.13%130.5M
6.49%156.67M
2.25%561.35M
-3.43%143.26M
Cost of revenue
2.81%77.26M
-10.70%74.6M
26.31%94.81M
13.57%304.63M
7.52%70.88M
19.39%75.16M
19.44%83.54M
8.13%75.06M
6.31%268.23M
-7.69%65.92M
Gross profit
24.72%79.88M
56.73%73.6M
-21.47%64.08M
-8.46%268.32M
-2.12%75.71M
-15.77%64.05M
-24.31%46.96M
5.03%81.61M
-1.19%293.12M
0.53%77.35M
Operating expense
1.96%64M
28.05%68.86M
6.47%72.01M
48.98%250.61M
18.49%66.43M
60.77%62.77M
48.64%53.78M
83.14%67.63M
11.03%168.22M
44.43%56.07M
Selling and administrative expenses
1.10%50.41M
29.07%54.54M
-0.47%55.86M
74.50%198.37M
21.74%50.13M
100.72%49.86M
78.41%42.26M
134.08%56.12M
24.43%113.68M
85.19%41.18M
-Selling and marketing expense
----
----
----
100.07%113.28M
----
----
----
----
46.90%56.62M
----
-General and administrative expense
----
----
----
49.12%85.09M
----
----
----
----
8.04%57.06M
----
Research and development costs
5.28%13.59M
24.33%14.33M
40.29%16.15M
-4.21%52.24M
9.50%16.31M
-9.11%12.91M
-7.79%11.52M
-11.15%11.51M
-9.33%54.54M
-10.22%14.89M
Operating profit
1,141.83%15.88M
169.55%4.74M
-156.68%-7.92M
-85.82%17.71M
-56.41%9.27M
-96.54%1.28M
-126.35%-6.82M
-65.72%13.98M
-13.95%124.91M
-44.17%21.28M
Net non-operating interest income expense
135.07%15.5M
225.23%13.97M
465.42%10.89M
154.67%20.85M
1,071.43%8.04M
215.41%6.59M
81.19%4.3M
-36.69%1.93M
-59.42%8.19M
-78.46%686K
Non-operating interest income
135.07%15.5M
225.23%13.97M
465.42%10.89M
124.62%22.1M
297.14%9.29M
215.41%6.59M
81.19%4.3M
-36.69%1.93M
-54.31%9.84M
-48.57%2.34M
Non-operating interest expense
----
----
----
-24.20%1.25M
----
----
----
----
21.28%1.65M
----
Other net income (expense)
51.04%1.97M
55.83%-1.06M
1,537.75%2.47M
99.36%-351K
-80.67%590K
209.76%1.3M
-302.11%-2.39M
100.25%151K
90.07%-55.23M
103.86%3.05M
Gain on sale of security
-81.30%138K
41.79%-1.62M
808.50%2.08M
-241.71%-2.81M
-118.46%-469K
235.66%738K
-1,156.06%-2.79M
-6.91%-294K
643.84%1.99M
201.66%2.54M
Special income (charges)
----
----
----
--0
----
----
----
----
89.01%-61.45M
--0
-Less:Other special charges
----
----
----
----
----
----
----
----
-89.01%61.45M
--0
Other non- operating income (expenses)
224.51%1.83M
43.29%566K
-12.36%390K
-41.76%2.46M
106.43%1.06M
-43.13%563K
-83.12%395K
15.89%445K
46.11%4.23M
407.92%513K
Income before tax
263.54%33.34M
459.35%17.66M
-66.11%5.44M
-50.92%38.21M
-28.45%17.9M
-76.78%9.17M
-116.70%-4.91M
199.84%16.05M
119.91%77.86M
166.25%25.02M
Income tax
588.83%13.14M
533.71%9.11M
-332.67%-4.59M
-34.83%12.77M
560.09%10.99M
-85.54%1.91M
-134.40%-2.1M
-26.56%1.97M
102.67%19.59M
73.10%-2.39M
Net income
178.16%20.21M
403.84%8.55M
-28.74%10.03M
-56.33%25.45M
-74.77%6.91M
-72.39%7.27M
-112.06%-2.81M
175.02%14.08M
114.54%58.27M
194.88%27.4M
Net income continuous Operations
178.16%20.21M
403.84%8.55M
-28.74%10.03M
-56.33%25.45M
-74.77%6.91M
-72.39%7.27M
-112.06%-2.81M
175.02%14.08M
114.54%58.27M
194.88%27.4M
Minority interest income
0
0
0
Net income attributable to the parent company
178.16%20.21M
403.84%8.55M
-28.74%10.03M
-56.33%25.45M
-74.77%6.91M
-72.39%7.27M
-112.06%-2.81M
175.02%14.08M
115.07%58.27M
192.00%27.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
178.16%20.21M
403.84%8.55M
-28.74%10.03M
-56.33%25.45M
-74.77%6.91M
-72.39%7.27M
-112.06%-2.81M
175.02%14.08M
115.07%58.27M
192.00%27.4M
Basic earnings per share
184.21%0.54
428.57%0.23
-27.03%0.27
-56.13%0.68
-75.34%0.18
-72.86%0.19
-111.29%-0.07
174.00%0.37
115.32%1.55
193.59%0.73
Diluted earnings per share
184.21%0.54
428.57%0.23
-27.03%0.27
-56.13%0.68
-75.34%0.18
-72.86%0.19
-111.29%-0.07
174.00%0.37
115.32%1.55
193.59%0.73
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022(Q1)Jun 30, 2022(FY)Mar 31, 2022(Q4)Mar 31, 2022
Total revenue 12.89%157.15M13.57%148.2M1.42%158.89M2.07%572.95M2.32%146.59M0.16%139.2M-1.13%130.5M6.49%156.67M2.25%561.35M-3.43%143.26M
Operating revenue 12.89%157.15M13.57%148.2M1.42%158.89M2.07%572.95M2.32%146.59M0.16%139.2M-1.13%130.5M6.49%156.67M2.25%561.35M-3.43%143.26M
Cost of revenue 2.81%77.26M-10.70%74.6M26.31%94.81M13.57%304.63M7.52%70.88M19.39%75.16M19.44%83.54M8.13%75.06M6.31%268.23M-7.69%65.92M
Gross profit 24.72%79.88M56.73%73.6M-21.47%64.08M-8.46%268.32M-2.12%75.71M-15.77%64.05M-24.31%46.96M5.03%81.61M-1.19%293.12M0.53%77.35M
Operating expense 1.96%64M28.05%68.86M6.47%72.01M48.98%250.61M18.49%66.43M60.77%62.77M48.64%53.78M83.14%67.63M11.03%168.22M44.43%56.07M
Selling and administrative expenses 1.10%50.41M29.07%54.54M-0.47%55.86M74.50%198.37M21.74%50.13M100.72%49.86M78.41%42.26M134.08%56.12M24.43%113.68M85.19%41.18M
-Selling and marketing expense ------------100.07%113.28M----------------46.90%56.62M----
-General and administrative expense ------------49.12%85.09M----------------8.04%57.06M----
Research and development costs 5.28%13.59M24.33%14.33M40.29%16.15M-4.21%52.24M9.50%16.31M-9.11%12.91M-7.79%11.52M-11.15%11.51M-9.33%54.54M-10.22%14.89M
Operating profit 1,141.83%15.88M169.55%4.74M-156.68%-7.92M-85.82%17.71M-56.41%9.27M-96.54%1.28M-126.35%-6.82M-65.72%13.98M-13.95%124.91M-44.17%21.28M
Net non-operating interest income expense 135.07%15.5M225.23%13.97M465.42%10.89M154.67%20.85M1,071.43%8.04M215.41%6.59M81.19%4.3M-36.69%1.93M-59.42%8.19M-78.46%686K
Non-operating interest income 135.07%15.5M225.23%13.97M465.42%10.89M124.62%22.1M297.14%9.29M215.41%6.59M81.19%4.3M-36.69%1.93M-54.31%9.84M-48.57%2.34M
Non-operating interest expense -------------24.20%1.25M----------------21.28%1.65M----
Other net income (expense) 51.04%1.97M55.83%-1.06M1,537.75%2.47M99.36%-351K-80.67%590K209.76%1.3M-302.11%-2.39M100.25%151K90.07%-55.23M103.86%3.05M
Gain on sale of security -81.30%138K41.79%-1.62M808.50%2.08M-241.71%-2.81M-118.46%-469K235.66%738K-1,156.06%-2.79M-6.91%-294K643.84%1.99M201.66%2.54M
Special income (charges) --------------0----------------89.01%-61.45M--0
-Less:Other special charges ---------------------------------89.01%61.45M--0
Other non- operating income (expenses) 224.51%1.83M43.29%566K-12.36%390K-41.76%2.46M106.43%1.06M-43.13%563K-83.12%395K15.89%445K46.11%4.23M407.92%513K
Income before tax 263.54%33.34M459.35%17.66M-66.11%5.44M-50.92%38.21M-28.45%17.9M-76.78%9.17M-116.70%-4.91M199.84%16.05M119.91%77.86M166.25%25.02M
Income tax 588.83%13.14M533.71%9.11M-332.67%-4.59M-34.83%12.77M560.09%10.99M-85.54%1.91M-134.40%-2.1M-26.56%1.97M102.67%19.59M73.10%-2.39M
Net income 178.16%20.21M403.84%8.55M-28.74%10.03M-56.33%25.45M-74.77%6.91M-72.39%7.27M-112.06%-2.81M175.02%14.08M114.54%58.27M194.88%27.4M
Net income continuous Operations 178.16%20.21M403.84%8.55M-28.74%10.03M-56.33%25.45M-74.77%6.91M-72.39%7.27M-112.06%-2.81M175.02%14.08M114.54%58.27M194.88%27.4M
Minority interest income 000
Net income attributable to the parent company 178.16%20.21M403.84%8.55M-28.74%10.03M-56.33%25.45M-74.77%6.91M-72.39%7.27M-112.06%-2.81M175.02%14.08M115.07%58.27M192.00%27.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 178.16%20.21M403.84%8.55M-28.74%10.03M-56.33%25.45M-74.77%6.91M-72.39%7.27M-112.06%-2.81M175.02%14.08M115.07%58.27M192.00%27.4M
Basic earnings per share 184.21%0.54428.57%0.23-27.03%0.27-56.13%0.68-75.34%0.18-72.86%0.19-111.29%-0.07174.00%0.37115.32%1.55193.59%0.73
Diluted earnings per share 184.21%0.54428.57%0.23-27.03%0.27-56.13%0.68-75.34%0.18-72.86%0.19-111.29%-0.07174.00%0.37115.32%1.55193.59%0.73
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg